000 01342 a2200397 4500
005 20250513021825.0
264 0 _c19800226
008 198002s 0 0 eng d
022 _a0022-3476
024 7 _a10.1016/s0022-3476(80)80344-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTruog, W E
245 0 0 _aAssociation of hemorrhagic disease and the syndrome of persistent fetal circulation with the fetal hydantoin syndrome.
_h[electronic resource]
260 _bThe Journal of pediatrics
_cJan 1980
300 _a112-4 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aFemale
650 0 4 _aHemorrhage
_xcomplications
650 0 4 _aHumans
650 0 4 _aInfant, Newborn
650 0 4 _aMale
650 0 4 _aPartial Thromboplastin Time
650 0 4 _aPersistent Fetal Circulation Syndrome
_xcomplications
650 0 4 _aPhenytoin
_xadverse effects
650 0 4 _aPregnancy
650 0 4 _aPregnancy Complications
650 0 4 _aProthrombin Time
650 0 4 _aSeizures
_xcomplications
650 0 4 _aSyndrome
650 0 4 _aVitamin K
_xtherapeutic use
700 1 _aFeusner, J H
700 1 _aBaker, D L
773 0 _tThe Journal of pediatrics
_gvol. 96
_gno. 1
_gp. 112-4
856 4 0 _uhttps://doi.org/10.1016/s0022-3476(80)80344-1
_zAvailable from publisher's website
999 _c7349798
_d7349798